Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
Authors
Keywords
-
Journal
Journal of the International AIDS Society
Volume 22, Issue 9, Pages -
Publisher
Wiley
Online
2019-09-17
DOI
10.1002/jia2.25372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential
- (2019) Caitlin M. Dugdale et al. ANNALS OF INTERNAL MEDICINE
- Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV
- (2018) Nikki Mulligan et al. AIDS
- Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners
- (2018) Kerry A Thomson et al. JOURNAL OF INFECTIOUS DISEASES
- Changes to dolutegravir policy in several African countries
- (2018) Esther Nakkazi LANCET
- Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV
- (2018) Jeremiah D. Momper et al. AIDS
- Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy
- (2018) Bonus Makanani et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The impact of highly active antiretroviral therapy on obstetric conditions: A review
- (2017) Hannah M. Sebitloane et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Research with Pregnant Women: New Insights on Legal Decision-Making
- (2017) Anna C. Mastroianni et al. HASTINGS CENTER REPORT
- Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials
- (2017) Felix G. Mhlanga et al. HIV CLINICAL TRIALS
- Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
- (2017) David A Margolis et al. LANCET
- Toward a universal antiretroviral regimen
- (2017) Amy L. Slogrove et al. Current Opinion in HIV and AIDS
- Why a universal antiretroviral regimen?
- (2017) Charles W. Flexner et al. Current Opinion in HIV and AIDS
- Research with pregnant women: a call to action
- (2017) Margaret Olivia Little et al. Reproductive Health
- Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy
- (2017) Rebecca Zash et al. JAMA Pediatrics
- Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis
- (2017) Olalekan A Uthman et al. Lancet HIV
- The pharmacokinetics of abacavir 600 mg once daily in HIV-1-positive pregnant women
- (2016) Stein Schalkwijk et al. AIDS
- Substantially lowered dolutegravir exposure in a treatment-experienced perinatally HIV-1-infected pregnant woman
- (2016) Stein Schalkwijk et al. AIDS
- The pregnant women as a drug orphan: a global survey of registered clinical trials of pharmacological interventions in pregnancy
- (2016) J Scaffidi et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Getting pregnant in HIV clinical trials: women’s choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials
- (2016) Alexandra Serris et al. HIV CLINICAL TRIALS
- A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research
- (2016) Mirjam J. Curno et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
- (2016) Mary G. Fowler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy
- (2015) Susie Huntington et al. AIDS
- Thalidomide-induced teratogenesis: History and mechanisms
- (2015) Neil Vargesson BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Maraviroc Pharmacokinetics in HIV-1–Infected Pregnant Women
- (2015) Angela Colbers et al. CLINICAL INFECTIOUS DISEASES
- In Utero Exposure to Zidovudine and Heart Anomalies in the ANRS French Perinatal Cohort and the Nested PRIMEVA Randomized Trial
- (2015) Jeanne Sibiude et al. CLINICAL INFECTIOUS DISEASES
- Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy
- (2015) Maren I. Blonk et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of tenofovir during pregnancy and postpartum
- (2015) BM Best et al. HIV MEDICINE
- Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
- (2015) Alice Stek et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study
- (2015) Nan Li et al. JOURNAL OF INFECTIOUS DISEASES
- Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room?
- (2015) Lynne M. Mofenson JOURNAL OF INFECTIOUS DISEASES
- Safety of efavirenz in the first trimester of pregnancy
- (2014) Nathan Ford et al. AIDS
- Atazanavir exposure is effective during pregnancy, regardless of tenofovir use
- (2014) Angela Colbers et al. ANTIVIRAL THERAPY
- Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study
- (2014) Elizabeth N Allen et al. BMC HEALTH SERVICES RESEARCH
- Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women*
- (2014) Angela Colbers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Consensus Report on the Detailed Fetal Anatomic Ultrasound Examination
- (2014) Joseph Wax et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants
- (2014) Lynne M. Mofenson et al. PLOS MEDICINE
- Association between Prenatal Exposure to Antiretroviral Therapy and Birth Defects: An Analysis of the French Perinatal Cohort Study (ANRS CO1/CO11)
- (2014) Jeanne Sibiude et al. PLOS MEDICINE
- Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-Analysis
- (2014) Alison L. Drake et al. PLOS MEDICINE
- Adverse events associated with nevirapine use in pregnancy
- (2013) Nathan Ford et al. AIDS
- Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy
- (2013) Regis Kreitchmann et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age
- (2012) Eric N. Ouattara et al. AIDS
- Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women
- (2012) Betty J. Dong et al. AIDS
- The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women
- (2012) Angela P.H. Colbers et al. AIDS
- Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire
- (2012) Patrick A Coffie et al. BMC INFECTIOUS DISEASES
- Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in Botswana
- (2012) J. Y. Chen et al. JOURNAL OF INFECTIOUS DISEASES
- Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings
- (2012) Ushma Mehta et al. BMC Pregnancy and Childbirth
- Safety of efavirenz in the first trimester of pregnancy
- (2011) Nathan Ford et al. AIDS
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
- (2011) Allen A. Mitchell et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Effect of pregnancy on emtricitabine pharmacokinetics
- (2011) AM Stek et al. HIV MEDICINE
- Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy
- (2011) Mark Mirochnick et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Prevalence of Congenital Anomalies in Infants With In Utero Exposure to Antiretrovirals
- (2011) Katherine M. Knapp et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts
- (2010) Nathan Ford et al. AIDS
- Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy
- (2010) Brookie M Best et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected Women
- (2010) Susan B. Brogly et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication
- (2010) Erika Aaron et al. PLoS One
- Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals
- (2009) David W Ouyang et al. AIDS
- Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults
- (2008) Jean B Nachega et al. AIDS
- Serious toxicity associated with continuous nevirapine-based HAART in pregnancy
- (2008) JE van Schalkwyk et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Lopinavir Exposure With an Increased Dose During Pregnancy
- (2008) Mark Mirochnick et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started